These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15653342)

  • 1. Synthesis and in vitro evaluation of new benzovesamicol analogues as potential imaging probes for the vesicular acetylcholine transporter.
    Zea-Ponce Y; Mavel S; Assaad T; Kruse SE; Parsons SM; Emond P; Chalon S; Giboureau N; Kassiou M; Guilloteau D
    Bioorg Med Chem; 2005 Feb; 13(3):745-53. PubMed ID: 15653342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural changes of benzylether derivatives of vesamicol and their influence on the binding selectivity to the vesicular acetylcholine transporter.
    Wenzel B; Sorger D; Heinitz K; Scheunemann M; Schliebs R; Steinbach J; Sabri O
    Eur J Med Chem; 2005 Dec; 40(12):1197-205. PubMed ID: 16095762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D QSAR study, synthesis, and in vitro evaluation of (+)-5-FBVM as potential PET radioligand for the vesicular acetylcholine transporter (VAChT).
    Kovac M; Mavel S; Deuther-Conrad W; Méheux N; Glöckner J; Wenzel B; Anderluh M; Brust P; Guilloteau D; Emond P
    Bioorg Med Chem; 2010 Nov; 18(21):7659-67. PubMed ID: 20889347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (E)-[125I]-5-AOIBV: a SPECT radioligand for the vesicular acetylcholine transporter.
    Emond P; Mavel S; Zea-Ponce Y; Kassiou M; Garreau L; Bodard S; Drossard ML; Chalon S; Guilloteau D
    Nucl Med Biol; 2007 Nov; 34(8):967-71. PubMed ID: 17998100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel 4- and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site.
    Scheunemann M; Sorger D; Wenzel B; Heinitz K; Schliebs R; Klingner M; Sabri O; Steinbach J
    Bioorg Med Chem; 2004 Mar; 12(6):1459-65. PubMed ID: 15018919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor.
    Shiba K; Ogawa K; Ishiwata K; Yajima K; Mori H
    Bioorg Med Chem; 2006 Apr; 14(8):2620-6. PubMed ID: 16434200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT).
    Kozaka T; Uno I; Kitamura Y; Miwa D; Ogawa K; Shiba K
    Bioorg Med Chem; 2012 Aug; 20(16):4936-41. PubMed ID: 22831799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine binding site in the vesicular acetylcholine transporter.
    Ojeda AM; Kolmakova NG; Parsons SM
    Biochemistry; 2004 Sep; 43(35):11163-74. PubMed ID: 15366926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New systematically modified vesamicol analogs and their affinity and selectivity for the vesicular acetylcholine transporter - A critical examination of the lead structure.
    Barthel C; Sorger D; Deuther-Conrad W; Scheunemann M; Schweiger S; Jäckel P; Roghani A; Steinbach J; Schüürmann G; Sabri O; Brust P; Wenzel B
    Eur J Med Chem; 2015 Jul; 100():50-67. PubMed ID: 26071858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter.
    Bando K; Naganuma T; Taguchi K; Ginoza Y; Tanaka Y; Koike K; Takatoku K
    Synapse; 2000 Oct; 38(1):27-37. PubMed ID: 10941138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational and pH analysis of ionic residues in transmembrane domains of vesicular acetylcholine transporter.
    Bravo DT; Kolmakova NG; Parsons SM
    Biochemistry; 2005 Jun; 44(22):7955-66. PubMed ID: 15924414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo and in vivo evaluation of (2R,3R)-5-[(18)F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter.
    Giboureau N; Emond P; Fulton RR; Henderson DJ; Chalon S; Garreau L; Roselt P; Eberl S; Mavel S; Bodard S; Fulham MJ; Guilloteau D; Kassiou M
    Synapse; 2007 Dec; 61(12):962-70. PubMed ID: 17787004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol.
    Jung YW; Frey KA; Mulholland GK; del Rosario R; Sherman PS; Raffel DM; Van Dort ME; Kuhl DE; Gildersleeve DL; Wieland DM
    J Med Chem; 1996 Aug; 39(17):3331-42. PubMed ID: 8765517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro evaluation of 5-substituted benzovesamicol analogs containing N-substituted amides as potential positron emission tomography tracers for the vesicular acetylcholine transporter.
    Roslin S; De Rosa M; Deuther-Conrad W; Eriksson J; Odell LR; Antoni G; Brust P; Larhed M
    Bioorg Med Chem; 2017 Oct; 25(19):5095-5106. PubMed ID: 28185725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporter.
    Efange SM; Khare AB; von Hohenberg K; Mach RH; Parsons SM; Tu Z
    J Med Chem; 2010 Apr; 53(7):2825-35. PubMed ID: 20218624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolovesamicols--synthesis, structure and VAChT binding of two 4-fluorobenzoyl regioisomers.
    Wenzel B; Li Y; Kraus W; Sorger D; Sabri O; Brust P; Steinbach J
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2163-6. PubMed ID: 22365760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First CoMFA characterization of vesamicol analogs as ligands for the vesicular acetylcholine transporter.
    Szymoszek A; Wenzel B; Scheunemann M; Steinbach J; Schüürmann G
    J Med Chem; 2008 Apr; 51(7):2128-36. PubMed ID: 18324757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxylated decahydroquinolines as ligands for the vesicular acetylcholine transporter: synthesis and biological evaluation.
    Efange SM; Khare AB; Mach RH; Parsons SM
    J Med Chem; 1999 Jul; 42(15):2862-9. PubMed ID: 10425095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane reorientation of the substrate-binding site in vesicular acetylcholine transporter.
    Bravo DT; Kolmakova NG; Parsons SM
    Biochemistry; 2004 Jul; 43(27):8787-93. PubMed ID: 15236587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological characterization of stable and radioiodinated (+/-)-trans-2-hydroxy-3-P[4-(3-iodophenyl)piperidyl]-1,2,3,4-tetrahydronaphthalene (3'-IBVM).
    Efange SM; von Hohenberg K ; Khare AB; Tu Z; Mach RH; Parsons SM
    Nucl Med Biol; 2000 Nov; 27(8):749-55. PubMed ID: 11150707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.